Cargando...
Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy
Immunostimulatory agents, including adjuvants, cytokines, and monoclonal antibodies, hold great potential for the treatment of cancer. However, their direct administration often results in suboptimal pharmacokinetics, vulnerability to biodegradation, and compromised targeting. More recently, encapsu...
Gardado en:
| Publicado en: | Theranostics |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Ivyspring International Publisher
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6831474/ https://ncbi.nlm.nih.gov/pubmed/31695803 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.37216 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|